Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis

@inproceedings{Stein2018OralVI,
  title={Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis},
  author={Juergen Stein and Jennifer S. Haas and Siew Hwa Ong and Kathrin Borchert and Thomas Hardt and E Lechat and Kerry Nip and Douglas Foerster and Sebastian Braun and Daniel C Baumgart},
  booktitle={ClinicoEconomics and outcomes research : CEOR},
  year={2018}
}
Background Iron-deficiency anemia and iron deficiency are common comorbidities associated with inflammatory bowel disease (IBD) resulting in impaired quality of life and high health care costs. Intravenous iron has shown clinical benefit compared to oral iron therapy. Aim This study aimed to compare health care outcomes and costs after oral vs intravenous iron treatment for IBD patients with iron deficiency or iron deficiency anemia (ID/A) in Germany. Methods IBD patients with ID/A were… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Similar Papers

Loading similar papers…